Serum resistin and polymorphisms of androgen receptor CAGn and GGNn and aromatase TTTAn

Obesity

Volumn 16, Issue 9, 2008, Pages 2107-2112

  Gonzalez Hernandez A ^a,b   Cabrera De Leon A ^a,b,c,d   Dominguez Coello, S ^a,b   Almeida Gonzalez D ^a,b   Rodriguez Perez M C ^a,b   Brito Diaz B ^a,b   Aguirre Jaime, A ^a,b   Diaz Chico B N ^a,e  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b Madrid Spain   (Spain)

^c San Juan de Dios Hospital   (Spain)

^d UNIVERSIDAD DE LA LAGUNA   (Spain)

^e UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; AROMATASE; C PEPTIDE; LEPTIN; MICROSATELLITE DNA; RESISTIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; AROMATASE; BLOOD GLUCOSE; C-PEPTIDE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RESISTIN; YOUNG ADULT;

EID: 50649113945     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.289     Document Type: Article

References (49)

1. Simon D, Preziosi P, Barrett-Connor E et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 1992;35:173-177.
2. Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996;45:1805-1609
3. Selvin E, Feinleib M, Zhang L et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2007;30:234-238.
4. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-494.
5. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002;25:55-60.
6. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. EurJ Endocrinol 2008;154:899-906.
7. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89:447-452.
8. Banerjee RR, Rangwala SM, Shapiro JS et al. Regulation of fasted blood glucose by resistin. Science 2004;303:1195-1198.
9. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2008;74:443-477.
10. Silha JV, Krsek M, Skrha JV et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003;149:331-335.
11. Fujinami A, Obayashi H, Ohta K et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004;339:57-63.
12. Bo S, Gambino R, Pagani A et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond) 2005;29:1315-1320.
13. Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005;7:406-413.
14. Perseghin G, Burska A, Lattuada G et al. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 2006;49:1893-1900.
15. Haluzik MM, Lacinova Z, Dolinkova M et al. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology 2006;147:4517-4524.
16. Chen CC, Li TC, Li CI et al. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005;54:471-475.
17. Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Dieguez C. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 2003;11:408-414.
18. Kochen Z, Karbowska J. Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol Cell Endocrinol 2004;218:57-64.
19. Huang SW, Seow KM, Ho LT et al. Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett 2005;579:449-454.
20. Ling C, Kindblom J, Wennbo H, Billig H. Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett 2001;507:147-150.
21. Panidis D, Koliakos G, Kourtis A et al. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 2004;81:361-366.
22. Munir I, Yen HW, Baruth T et al. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4852-4857.
23. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85-96.
24. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate 2004;58:23-32.
25. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 2005;62:133-139.
26. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
27. Westberg L, Baghaei F, Rosmond R et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001;86:2562-2868.
28. Brum IS, Spritzer PM, Paris F et al. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. J Soc Gynecol lnvestig 2005;12:135-141.
29. Crabbe P, Bogaert V, De Bacquer et al. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback setpoint: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 2007;92:3604-3610.
30. Gennari L, Masi L, Merlotti D et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab 2004;89:2803-2810.
31. Baghaei F, Rosmond R, Westberg L et al. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 2003;11:578-585.
32. Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 2003;46:31-39.
33. Mohlig M, Jurgens A, Spranger J et al. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 2006;155:127-130.
34. Cabrera de León A, Rodríguez-Péz MC, del Castillo-Rodríguez JUL et al. Coronary risk in the population of the Canary Islands using the Framingham function. Med Clin (Barc) 2006;126:521-526.
35. Cabrera de León A, Rodríguez-PéMC, Rodríumeda LM et al. Sedentary life style: physical activity duration versus percentage of energy expenditure. Rev Esp Cardiol 2007;60:244-250.
36. Bharaj BS, Vassilikos EJ, Diamandis EP. Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem 1999;32:327-332.
37. Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 1993;2:493.
38. Kado N, Kitawaki J, Obayashi H et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897-902.
39. Nogueiras R, Barreiro ML, Caminos JE et al. Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors. J Cell Sci 2004;117:3247-3257.
40. Tejero ME, Freeland-Graves JH, Proffitt JM et al. Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons. Obes Res 2004;12:871-877.
41. Menzaghi C, Coco A, Salvemini Let al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 2006;91:2792-2795.
42. Pantsulaia I, Livshits G, Trofimov S, Kobyliansky E. Genetic and environmental determinants of circulating resistin level in a community-based sample. Eur J Endocrinol 2007;156:129-135.
43. Alevizaki M, Cimponeriu AT, Garofallaki M et al. The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol (Oxf) 2003;59:749-755.
44. Walsh S, Zmuda JM, Cauley JA et al. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol 2005;98:132-137.
45. Lundin KB, Giweroman A, Dizeyi N, Giweroman YL. Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 2007;264:184-187.
46. Aschim EL, Nordenskjold A, Giweroman A et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004;89:5105-5109.
47. Berstein LM, Imyanitov EN, Suspitsin EN et al. CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol 2001;127:135-138.
48. Probst-Hensch NM, Ingles SA, Diep AT et al. Aromatase and breast cancer susceptibility. Endocr Relat Cancer 1999;6:165-173.
49. Heiman CA, Hankinson SE, Spiegelman D et al. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 2000;87:204-210.